Navigation Links
Alexza Completes Enrollment in Phase 3 Clinical Trial with AZ-004 (Staccato(R) Loxapine) for Acute Agitation
Date:6/9/2008

A HREF="http://www.alexza.com/investor_section/news_events.php" target="_new">http://www.alexza.com/investor_section/news_events.php

The replay of the conference call may be accessed via the Internet, at http://www.alexza.com, or via phone at 1-888-286-8010 for domestic callers or 1-617- 801-6888 for international callers. The reference number to enter the replay of the call is 95055607.

About Acute Agitation

Acute agitation, characterized by unpleasant arousal, tension, irritability and hostility, is one of the most common and severe symptoms of many major psychiatric disorders, including schizophrenia and bipolar disorder. According to the National Institute of Mental Health (NIMH), schizophrenia afflicts about 6.0 million adults in the United States and bipolar disorder affects about 5.7 million American adults. Company-sponsored market research indicates that over 90% of these patients will experience agitation during their lifetime and that about 70% of those who experience agitation will have one to six episodes per year. Agitated patients are often treated in an emergency room setting, and are also treated as in-patients in psychiatric hospitals or psychiatric units in standard hospitals.

Market research indicates that physicians currently treat acute agitation with intramuscular (IM) injections, rapid-dissolve tablets or standard tablets. IM injections are invasive, can be disconcerting to patients as they often require the use of restraints, and can be dangerous to the medical personnel while they attempt to inject the patient. IM injections can also take up to 60 minutes to work. Oral tablets provide convenience of dosing but have a slower onset of action. Market research among physicians has identified speed of onset as an important factor that affects their choice of therapy for treating acute agitation. Published literature suggests that many patients with schizophrenia or
'/>"/>

SOURCE Alexza Pharmaceuticals, Inc.
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7

Related medicine technology :

1. Alexza Completes Target Enrollment in AZ-104 Phase 2a Clinical Trial in Migraine Patients
2. Alexza Initiates AZ-007 (Staccato(R) Zaleplon) Phase 1 Clinical Trial and Updates Clinical Pipeline Development Status
3. Alexzas AZ-104 (Staccato(R) Loxapine) Phase 2a Trial Meets Primary Endpoint of 2-Hour Pain Relief in Patients with Migraine Headache
4. Alexza Reports 2007 Year-End Financial Results and Updates Clinical Pipeline Status
5. Alexza Announces Positive Phase 1 Results With AZ-007 (Staccato(R) Zaleplon)
6. Alexza Completes Enrollment in Phase 2a Clinical Trial With AZ-002 (Staccato(R) Alprazolam) in Panic Disorder Patients
7. Alexza Pharmaceuticals to Present AZ-004 Phase 2a Clinical Data at the American Psychiatric Association Annual Meeting
8. Alexza Announces Preliminary Results From its AZ-002 (Staccato(R) Alprazolam) Phase 2a Proof-of-Concept Trial in Patients With Panic Disorder
9. Harvard Medical School-Partners HealthCare Center for Genetics and Genomics Successfully Completes Evaluation of AutoGenomics 2C9-VKORC1 Panel to Assess Warfarin Sensitivity
10. Vion Pharmaceuticals Completes Accrual of 85 Patients to its Pivotal Phase II Trial of Cloretazine(R) (VNP40101M) in Elderly AML
11. TaiGen Biotechnology Successfully Completes Patient Recruitment for Phase II Trial of Nemonoxacin for Treatment of Adult Community Acquired Pneumonia (CAP)
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/21/2014)... percent of Americans believe the abuse of strong prescription pain ... safety issue in the United States , ... & Partners, a Cincinnati based research ... the prescription medication abuse problem and the need for medical ... facing our country," Rex Repass , CEO of the ...
(Date:8/21/2014)... 21, 2014 InfinityQS International, Inc., the ... Intelligence , today announces Infusion Chicago, its 9 ... be held Oct. 9-10, 2014, at the Chicago ... showcase the necessity for implementing a quality system ... Intelligence to gain insight into production processes. Complimentary ...
(Date:8/21/2014)... -- Professional Compounding Centers of America (PCCA) will ... three best scientific presentations at the sixth ... Formulating Better Medicines for Children  conference, held ... Greece , includes dozens of poster-style scientific ... three winners will be selected by a panel ...
Breaking Medicine Technology:Consumers Desperate For Measures To Curb Prescription Drug Abuse 2Consumers Desperate For Measures To Curb Prescription Drug Abuse 3InfinityQS to Host Manufacturing Intelligence Conference in Chicago 2Professional Compounding Centers of America will award top poster-session winners at European Paediatric Formulation Initiative in Athens 2
... Food and Drug Administration today allowed marketing of the first ... dengue fever or dengue hemorrhagic fever, a leading cause of ... (Logo:   http://photos.prnewswire.com/prnh/20090824/FDALOGO ) The dengue ... infected Aedes mosquito. As many as 100 million ...
... 2011 The U.S. Food and Drug Administration today cleared ... assay that is designed to rapidly detect the toxin B ... cause of diarrhea that can lead to colitis, other serious ... http://photos.prnewswire.com/prnh/20090824/FDALOGO ) Clostridium difficile ( ...
Cached Medicine Technology:FDA Permits Marketing of First Test to Help Diagnose Dengue Fever 2FDA Permits Marketing of First Test to Help Diagnose Dengue Fever 3FDA Clears Test for Bacteria That Can Cause Serious Intestinal Disease 2
(Date:8/21/2014)... Hunhu Healthcare, Inc. , a Minneapolis-based ... it has entered into a licensing agreement with Mayo ... predictive analytics for recruiting, leveraging and managing its solution ... Michael Emerson , co-founder and CEO of Hunhu Healthcare, ... technology used in what he calls a social wellness ...
(Date:8/21/2014)... 2014 Quantum Innovations, Inc . ... to announce the healthcare technology platform, PWeR® 2.0 ... , The company anticipates provisioning its first provider over ... individual physicians, via interfaces, to medical laboratory, pharmacy, secure ... electronic data exchanges and medical clearing houses. , ...
(Date:8/21/2014)... According to new market research report, “Lactic ... Beverage, Personal care & Pharmaceutical) & Polylactic acid ... & Geography - Global Trends & Forecasts to ... markets and segments with analyses and projections of ... sub-segments, in terms of value and volume. It ...
(Date:8/21/2014)... 2014 Being overweight or obese may ... Although there is no cure, patients have learned ... lifestyle changes, such as losing excess weight and following ... is a joint disorder which causes discomfort and pain ... and can significantly reduce one’s quality of life. Although ...
(Date:8/21/2014)... Louis, MO (PRWEB) August 21, 2014 ... wellness in all aspects of life, St. Louis’ Sound ... for the better and revolutionized its online presence. Reorganized ... Mind Café, the new website makes navigating for information ... blue and an easily accessible menu-bar in jet black, ...
Breaking Medicine News(10 mins):Health News:Hunhu Healthcare Enters into Licensing Agreement with Mayo Clinic 2Health News:Grace Century’s Electronic Health Records Project, Quantum Innovations, Announces That PWeR® Healthcare Technology Platform is Ready for Deployment 2Health News:Grace Century’s Electronic Health Records Project, Quantum Innovations, Announces That PWeR® Healthcare Technology Platform is Ready for Deployment 3Health News:Grace Century’s Electronic Health Records Project, Quantum Innovations, Announces That PWeR® Healthcare Technology Platform is Ready for Deployment 4Health News:Lactic Acid Market Worth $3,577.5 Million & Polylactic Acid Market Worth $4,840.1 Million by 2019 – New Report 2Health News:Lactic Acid Market Worth $3,577.5 Million & Polylactic Acid Market Worth $4,840.1 Million by 2019 – New Report 3Health News:Diet Doc’s Medical Weight Loss Programs Announces Safe and Fast Weight Loss That Teach Patients How to Relieve Osteoarthritis Pain 2Health News:Diet Doc’s Medical Weight Loss Programs Announces Safe and Fast Weight Loss That Teach Patients How to Relieve Osteoarthritis Pain 3Health News:Sound Mind Cafe Launches Revamped Website and Hires Hypnotist to Team 2
... researchers say , FRIDAY, April 9 (HealthDay News) -- Children ... vaccines contained both strains of influenza B instead of just ... a second influenza B virus strain to the seasonal influenza ... selection and help improve the vaccine,s ability to prevent influenza," ...
... The commitment to health by country governments in the developing ... to a new study by the Institute for Health Metrics ... Medical School. Overall domestic government spending on health ... billion in 2006, the study shows. That is three times ...
... , ... developer for his own use, this hand polished and sculpted mouse pad is now available ... functional addition to any desktop. , ... (PRWEB) April 9, 2010 -- Dxtra Announces the availability of the world,s only solid ...
... should be paid to prevention and treatment, expert says ... can create serious problems for smokers who have a ... to a new study. , Researchers from Caen University ... nicotine withdrawal can become highly agitated and accidentally remove ...
... ... raise awareness of violence and abuse , ... Washington, D.C. (Vocus) April 9, 2010 -- Children,s National Medical Center,s Teen Life ... artwork designed by youth who have been affected by violence or abuse. , , , ...
... social security fund on a global scale. That is what ... in a Viewpoint in the leading medical journal The ... the use of international donor money a lot more transparent ... cannot be traced in the budgets of the receiving countries. ...
Cached Medicine News:Health News:Flu Vaccine With Both B Strains May Offer Better Protection 2Health News:Developing countries devote more funding to health, except many in sub-Saharan Africa 2Health News:Developing countries devote more funding to health, except many in sub-Saharan Africa 3Health News:Nicotine Withdrawal Can Complicate Hospital Care 2Health News:Children's National Hosts Fourth Annual Youth Anti-Violence Exhibition 2Health News:Children's National Hosts Fourth Annual Youth Anti-Violence Exhibition 3Health News:Why we need a world social health insurance 2
The Model 273 is a general purpose instrument with output that may be either DC-coupled for very slow changes such as venous occlusion and penile tumescence studies or AC-coupled for respiratory or p...
... Plastic and fabric specialty drapes ... gynecology. Steri-Drape absorbent prevention fabric ... fluid strike-through reducing the need ... Drape Pack, Op tape, Hand ...
... top design takes into account a wide ... flexible working environment for the surgical team. ... be matched exactly to your patients height. ... creates superior access for image amplification procedures. ...
... Mitek is the Market leader in soft ... Suture, DePuy Mitek has developed the latest ... open shoulder repair. ORTHOCORD Suture is as ... the market. Most importantly, ORTHOCORD Suture handles ...
Medicine Products: